US Food and Drug Administration Agency Analysis

US Food and Drug Administration Agency Analysis

ORDER A PLAGIARISM FREE PAPER NOW

Running head: AGENCY SELECTION 1 Agency Selection Natashia Richmond PAD 599 Dr. A. Smith April 19, 2020 AGENCY SELECTION 2 Agency Selection Food and Drug Administration (FDA) The rationale for Agency Selected Introduction The Federal Drug Administration is one of the federal agencies in the United States Department of Health and Human Services. The agency was founded in 1906 under the administration of President Theodore Roosevelt. The agency has its headquarters in White Oak Campus, New Hampshire Avenue. Silver Spring, Maryland. The primary responsibility of the agency is to promote the safety of “food, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics, animal foods & feed and veterinary products.” Mission “The Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation’s food supply, cosmetics, and products that emit radiation” (FDA, 2020). Goals and objectives – Protect public health – Regulate tobacco use – Speed up innovations in health AGENCY SELECTION – 3 Ensuring the security of food supply in the country Functions of the Agency The Federal Drug Administration is one of the most important agencies since it is at the heart of the country’s health systems. Firstly, this agency has the function of making sure that the drugs that are being manufactured by the country’s medicines are safe. Since most drugs are developed by private enterprises, it is necessary for the government to make sure the drugs that they manufacture will not hurt the public. Another important function of this organization is to regulate tobacco use. This organization is responsible for making sure that it regulates the production and marketing of tobacco in a manner that protects the public (Carpenter, 2014). It is also the responsibility of the organization to make sure that it encourages innovation in the field of healthcare. The agency also plays an important role in making sure that there is food security in the United States by making sure that there is a steady and consistent supply. Current Events One of the current events concerning the organization is the coronavirus pandemic. The pandemic is s global crisis that has brought the world to a stop. In the face of these challenges, many organizations are coming up with medications and vaccines to address the virus. It is the responsibility of the organization to make sure that these medications and vaccines that are being developed meet the desired quality standards (Prompetchara et al., 2020). The second event that concerns the agency is the surge in the number of counterfeit drugs in the market. There are reports that there are many medications that have sneaked into the market without going through the regulatory tests (Blackstone et al., 2014). There is a need to find the mechanisms through which the organization may prevent the entry of untested drugs into the market. AGENCY SELECTION 4 Rationale The primary reason for settling on this organization is related to the purpose of the organization in the management of the present pandemic. The Federal Drug Administration is responsible for making sure that there are drugs that may be used to safely address the pandemic. At this time, the agency is required to put its best foot forward and make sure that there are adequate measures to test the safety of emerging COVID-19 drugs. The second reason for the selection of this agency is its role in protecting Americans from the drugs that are being brought into the market illegally. AGENCY SELECTION 5 References Blackstone, E. A., Fuhr Jr, J. P., & Pociask, S. (2014). The health and economic effects of counterfeit drugs. American health & drug benefits, 7(4), 216. Carpenter, D. (2014). Reputation and power: organizational image and pharmaceutical regulation at the FDA (Vol. 137). Princeton University Press. Prompetchara, E., Ketloy, C., & Palaga, T. (2020). Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol, 38(1), 1-9. U.S Food and Drug Administration. (2020). What We Do. Retrieved from https://www.fda.gov/about-fda/what-we-do
Purchase answer to see full attachment